New Typhoid Conjugate Vaccine Receives WHO Prequalification

The recent prequalification of the new typhoid conjugate vaccine, SKYTyphoid™, by the World Health Organization (WHO) marks a pivotal moment in global health, opening the doors for public procurement of the vaccine by UN organizations. Developed through collaboration and with funding support, SKYTyphoid™ represents a significant advancement in typhoid prevention, offering a safe and effective solution for infants and young children. The achievement of WHO prequalification for SKYTyphoid™ marks a significant step forward in global health, offering a promising solution for the prevention of typhoid and contributing to the accessibility of life-saving vaccines for vulnerable populations worldwide.